{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T19:14:35Z","timestamp":1769973275490,"version":"3.49.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2018,3,7]],"date-time":"2018-03-07T00:00:00Z","timestamp":1520380800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81401057"],"award-info":[{"award-number":["81401057"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81401055"],"award-info":[{"award-number":["81401055"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81571258"],"award-info":[{"award-number":["81571258"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1007\/s12035-018-0952-9","type":"journal-article","created":{"date-parts":[[2018,3,7]],"date-time":"2018-03-07T04:03:30Z","timestamp":1520395410000},"page":"8179-8187","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["CYP46A1 and the APOE\u03b54 Allele Polymorphisms Correlate with the Risk of Alzheimer\u2019s Disease"],"prefix":"10.1007","volume":"55","author":[{"given":"Ling","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fan","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Hui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui-Yun","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu-Yang","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ze-Yan","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan-Jiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0641-1199","authenticated-orcid":false,"given":"Hua-Dong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,3,7]]},"reference":[{"key":"952_CR1","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.molmed.2005.02.009","volume":"11","author":"FM LaFerla","year":"2005","unstructured":"LaFerla FM, Oddo S (2005) Alzheimer\u2019s disease: Abeta, tau and synaptic dysfunction. Trends Mol Med 11:170\u2013176","journal-title":"Trends Mol Med"},{"key":"952_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1749-6632.2000.tb05552.x","volume":"924","author":"PH St George-Hyslop","year":"2000","unstructured":"St George-Hyslop PH (2000) Genetic factors in the genesis of Alzheimer\u2019s disease. Ann N Y Acad Sci 924:1\u20137","journal-title":"Ann N Y Acad Sci"},{"key":"952_CR3","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S0074-7742(09)00409-7","volume":"84","author":"L Bertram","year":"2009","unstructured":"Bertram L (2009) Alzheimer\u2019s disease genetics current status and future perspectives. Int Rev Neurobiol 84:167\u2013184","journal-title":"Int Rev Neurobiol"},{"key":"952_CR4","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/nrneurol.2012.263","volume":"9","author":"CC Liu","year":"2013","unstructured":"Liu CC, Kanekiyo T, Xu H, Bu G (2013) Apolipoprotein E and Alzheimer disease: risk, mechanisms, and therapy. Nat Rev Neurol 9:106\u2013118","journal-title":"Nat Rev Neurol"},{"key":"952_CR5","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/ng0694-180","volume":"7","author":"EH Corder","year":"1994","unstructured":"Corder EH, Saunders AM, Risch NJ, Strittmatte r WJ, Schmechel DE, Gaskell PC Jr, Rimmler JB, Locke PA et al (1994) Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nat Genet 7:180\u2013184","journal-title":"Nat Genet"},{"key":"952_CR6","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1126\/science.8346443","volume":"261","author":"EH Corder","year":"1993","unstructured":"Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL et al (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer\u2019s disease in late onset families. Science 261:921\u2013923","journal-title":"Science"},{"key":"952_CR7","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1212\/WNL.43.8.1467","volume":"43","author":"AM Saunders","year":"1993","unstructured":"Saunders AM, Strittmatter WJ, Schmechel D, George-Hyslop PH, Pericak-Vance MA, Joo SH, Rosi BL, Gusella JF et al (1993) Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer\u2019s disease. Neurology 43:1467\u20131472","journal-title":"Neurology"},{"key":"952_CR8","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/ng1934","volume":"39","author":"L Bertram","year":"2007","unstructured":"Bertram L, McQueen MB, Mullin K, Blacker D, Tanzi RE (2007) Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database. Nat Genet 39:17\u201323","journal-title":"Nat Genet"},{"key":"952_CR9","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1111\/j.1471-4159.2009.06408.x","volume":"111","author":"IJ Martins","year":"2009","unstructured":"Martins IJ, Berger T, Sharman MJ, Verdile G, Fuller SJ, Martins RN (2009) Cholesterol metabolism and transport in the pathogenesis of Alzheimer\u2019s disease. J Neurochem 111:1275\u20131308","journal-title":"J Neurochem"},{"key":"952_CR10","doi-asserted-by":"publisher","first-page":"2710","DOI":"10.1016\/j.bbamem.2008.07.014","volume":"1778","author":"G D'Errico","year":"2008","unstructured":"D'Errico G, Vitiello G, Ortona O, Tedeschi A, Ramunno A, D'Ursi AM (2008) Interaction between Alzheimer\u2019s Abeta (25\u201335) peptide and phospholipid bilayers: the role of cholesterol. Biochim Biophys Acta 1778:2710\u20132716","journal-title":"Biochim Biophys Acta"},{"key":"952_CR11","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1002\/psc.1207","volume":"16","author":"G Vitiello","year":"2010","unstructured":"Vitiello G, Grimaldi M, Ramunno A, Ortona O, De Martino G, D'Ursi AM, D'Errico G (2010) Interaction of a beta-sheet breaker peptide with lipid membranes. J Pept Sci 16:115\u2013122","journal-title":"J Pept Sci"},{"key":"952_CR12","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1006\/exnr.1994.1044","volume":"126","author":"DL Sparks","year":"1994","unstructured":"Sparks DL, Scheff SW, Hunsaker JC 3rd, Liu H, Landers T, Gross DR (1994) Induction of Alzheimer-like beta-amyloid immunoreactivity in the brains of rabbits with dietary cholesterol. Exp Neurol 126:88\u201394","journal-title":"Exp Neurol"},{"key":"952_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3233\/JAD-2002-4101","volume":"4","author":"P Zatta","year":"2002","unstructured":"Zatta P, Zambenedetti P, Stella MP, Licastro F (2002) Astrocytosis, microgliosis, metallothionein-I-II and amyloid expression in high cholesterol-fed rabbits. J Alzheimers Dis 4:1\u20139","journal-title":"J Alzheimers Dis"},{"key":"952_CR14","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1016\/S0140-6736(00)03155-X","volume":"356","author":"H Jick","year":"2000","unstructured":"Jick H, Zornberg GL, Jick SS, Seshadri S, Drachman DA (2000) Statins and the risk of dementia. Lancet 356:1627\u20131631","journal-title":"Lancet"},{"key":"952_CR15","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1001\/archneur.57.10.1439","volume":"57","author":"B Wolozin","year":"2000","unstructured":"Wolozin B, Kellman W, Ruosseau P, Celesia GG, Siegel G (2000) Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors. Arch Neurol 57:1439\u20131443","journal-title":"Arch Neurol"},{"key":"952_CR16","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1172\/JCI104631","volume":"41","author":"AV Chobanian","year":"1962","unstructured":"Chobanian AV, Hollander W (1962) Body cholesterol metabolism in man. I. The equilibration of serum and tissue cholesterol. J Clin Invest 41:1732\u20131737","journal-title":"J Clin Invest"},{"key":"952_CR17","doi-asserted-by":"publisher","first-page":"9799","DOI":"10.1073\/pnas.93.18.9799","volume":"93","author":"D Lutjohann","year":"1996","unstructured":"Lutjohann D, Breuer O, Ahlborg G, Nennesmo I, Siden A, Diczfalusy U, Bjorkhem I (1996) Cholesterol homeostasis in human brain: evidence for an age-dependent flux of 24S-hydroxycholesterol from the brain into the circulation. Proc Natl Acad Sci U S A 93:9799\u20139804","journal-title":"Proc Natl Acad Sci U S A"},{"key":"952_CR18","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1016\/S0022-2275(20)32188-X","volume":"39","author":"I Bjorkhem","year":"1998","unstructured":"Bjorkhem I, Lutjohann D, Diczfalusy U, Stahle L, Ahlborg G, Wahren J (1998) Cholesterol homeostasis in human brain: turnover of 24S-hydroxycholesterol and evidence for a cerebral origin of most of this oxysterol in the circulation. J Lipid Res 39:1594\u20131600","journal-title":"J Lipid Res"},{"key":"952_CR19","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0022-2275(20)32052-6","volume":"41","author":"D Lutjohann","year":"2000","unstructured":"Lutjohann D, Papassotiropoulos A, Bjorkhem I, Locatelli S, Bagli M, Oehring RD, Schlegel U, Jessen F et al (2000) Plasma 24S-hydroxycholesterol (cerebrosterol) is increased in Alzheimer and vascular demented patients. J Lipid Res 41:195\u2013198","journal-title":"J Lipid Res"},{"key":"952_CR20","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S0022-3956(01)00050-4","volume":"36","author":"A Papassotiropoulos","year":"2002","unstructured":"Papassotiropoulos A, Lutjohann D, Bagli M, Locatelli S, Jessen F, Buschfort R, Ptok U, Bjorkhem I et al (2002) 24S-hydroxycholesterol in cerebrospinal fluid is elevated in early stages of dementia. J Psychiatr Res 36:27\u201332","journal-title":"J Psychiatr Res"},{"key":"952_CR21","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/j.neurobiolaging.2009.04.022","volume":"32","author":"MG Martin","year":"2011","unstructured":"Martin MG, Trovo L, Perga S, Sadowska A, Rasola A, Chiara F, Dotti CG (2011) Cyp46-mediated cholesterol loss promotes survival in stressed hippocampal neurons. Neurobiol Aging 32:933\u2013943","journal-title":"Neurobiol Aging"},{"key":"952_CR22","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1007\/s12031-009-9227-2","volume":"39","author":"AN Garcia","year":"2009","unstructured":"Garcia AN, Muniz MT, Souza e Silva HR, da Silva HA, Athayde-Junior L (2009) Cyp46 polymorphisms in Alzheimer\u2019s disease: a review. J Mol Neurosci 39:342\u2013345","journal-title":"J Mol Neurosci"},{"key":"952_CR23","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/j.neurobiolaging.2003.08.004","volume":"25","author":"B Borroni","year":"2004","unstructured":"Borroni B, Archetti S, Agosti C, Akkawi N, Brambilla C, Caimi L, Caltagirone C, Di Luca M et al (2004) Intronic CYP46 polymorphism along with ApoE genotype in sporadic Alzheimer disease: from risk factors to disease modulators. Neurobiol Aging 25:747\u2013751","journal-title":"Neurobiol Aging"},{"key":"952_CR24","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1136\/jnnp.2005.071928","volume":"77","author":"S Helisalmi","year":"2006","unstructured":"Helisalmi S, Veps\u00e4l\u00e4inen S, Koivisto AM, Mannermaa A, Iivonen S, Hiltunen M, Kiviniemi V, Soininen H (2006) Association of CYP46 intron 2 polymorphism in Finnish Alzheimer\u2019s disease samples and a global scale summary. J Neurol Neurosurg Psychiatry 77:421\u2013422","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"952_CR25","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1159\/000095723","volume":"22","author":"Y Li","year":"2006","unstructured":"Li Y, Chu LW, Chen YQ, Cheung BMY, Leung RYH, Yik PY, Ng KM, Mak W et al (2006) Intron 2 (T\/C) CYP46 polymorphism is associated with Alzheimer\u2019s disease in Chinese patients. Dement Geriatr Cogn Disord 22:399\u2013404","journal-title":"Dement Geriatr Cogn Disord"},{"key":"952_CR26","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1007\/s12031-012-9778-5","volume":"47","author":"XM He","year":"2012","unstructured":"He XM, Zhang ZX, Zhang JW, Zhou YT, Wu CB, Tang MN, Hong Z (2012) An intronic CYP46A1 polymorphism is associated with Alzheimer disease in a Chinese Han population. J Mol Neurosci 47:514\u2013518","journal-title":"J Mol Neurosci"},{"key":"952_CR27","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1001\/archneur.60.1.29","volume":"60","author":"A Papassotiropoulos","year":"2003","unstructured":"Papassotiropoulos A, Streffer JR, Tsolaki M, Schmid S, Thal D, Nicosia F, Iakovidou V, Maddalena A et al (2003) Increased brain beta-amyloid load, phosphorylated tau, and risk of Alzheimer disease associated with an intronic CYP46 polymorphism. Arch Neurol 60:29\u201335","journal-title":"Arch Neurol"},{"key":"952_CR28","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.eurpsy.2008.12.005","volume":"24","author":"H Kolsch","year":"2009","unstructured":"Kolsch H, Lutjohann D, Jessen F, Popp J, Hentschel F, Kelemen P, Schmitz S, Maier W et al (2009) CYP46A1 variants influence Alzheimer\u2019s disease risk and brain cholesterol metabolism. Eur Psychiatry 24:183\u2013190","journal-title":"Eur Psychiatry"},{"key":"952_CR29","doi-asserted-by":"publisher","first-page":"773.e771","DOI":"10.1016\/j.neurobiolaging.2005.03.029","volume":"27","author":"A Tedde","year":"2006","unstructured":"Tedde A, Rotondi M, Cellini E, Bagnoli S, Muratore L, Nacmias B, Sorbi S (2006) Lack of association between the CYP46 gene polymorphism and Italian late-onset sporadic Alzheimer\u2019s disease. Neurobiol Aging 27:773.e771\u2013773.e773","journal-title":"Neurobiol Aging"},{"key":"952_CR30","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.brainres.2007.02.005","volume":"1147","author":"F Wang","year":"2007","unstructured":"Wang F, Jia J (2007) Polymorphisms of cholesterol metabolism genes CYP46 and ABCA1 and the risk of sporadic Alzheimer\u2019s disease in Chinese. Brain Res 1147:34\u201338","journal-title":"Brain Res"},{"key":"952_CR31","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1007\/s00415-012-6690-4","volume":"260","author":"L Li","year":"2013","unstructured":"Li L, Yin Z, Liu J, Li G, Wang Y, Yan J, Zhou H (2013) CYP46A1 T\/C polymorphism associated with the APOE epsilon4 allele increases the risk of Alzheimer\u2019s disease. J Neurol 260:1701\u20131708","journal-title":"J Neurol"},{"key":"952_CR32","doi-asserted-by":"publisher","first-page":"7238","DOI":"10.1073\/pnas.96.13.7238","volume":"96","author":"EG Lund","year":"1999","unstructured":"Lund EG, Guileyardo JM, Russell DW (1999) cDNA cloning of cholesterol 24-hydroxylase, a mediator of cholesterol homeostasis in the brain. Proc Natl Acad Sci U S A 96:7238\u20137243","journal-title":"Proc Natl Acad Sci U S A"},{"key":"952_CR33","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1017\/S1041610205003108","volume":"18","author":"SL Ma","year":"2006","unstructured":"Ma SL, Tang NLS, Lam LCW, Chiu HFK (2006) Polymorphisms of the cholesterol 24-hydroxylase (CYP46A1) gene and the risk of Alzheimer\u2019s disease in a Chinese population. Int Psychogeriatr 18:37\u201345","journal-title":"Int Psychogeriatr"},{"key":"952_CR34","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1016\/j.bbalip.2015.02.010","volume":"1851","author":"G Saher","year":"2015","unstructured":"Saher G, Stumpf SK (2015) Cholesterol in myelin biogenesis and hypomyelinating disorders. Biochim Biophys Acta 1851:1083\u20131094","journal-title":"Biochim Biophys Acta"},{"key":"952_CR35","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1212\/WNL.59.8.1257","volume":"59","author":"K Fassbender","year":"2002","unstructured":"Fassbender K, Stroick M, Bertsch T, Ragoschke A, Kuehl S, Walter S, Walter J, Brechtel K et al (2002) Effects of statins on human cerebral cholesterol metabolism and secretion of Alzheimer amyloid peptide. Neurology 59:1257\u20131258","journal-title":"Neurology"},{"key":"952_CR36","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.neulet.2009.06.073","volume":"462","author":"A Solomon","year":"2009","unstructured":"Solomon A, Leoni V, Kivipelto M, Besga A, Oksengard AR, Julin P, Svensson L, Wahlund LO et al (2009) Plasma levels of 24S-hydroxycholesterol reflect brain volumes in patients without objective cognitive impairment but not in those with Alzheimer\u2019s disease. Neurosci Lett 462:89\u201393","journal-title":"Neurosci Lett"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12035-018-0952-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-018-0952-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-018-0952-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,15]],"date-time":"2022-08-15T12:54:52Z","timestamp":1660568092000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12035-018-0952-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,7]]},"references-count":36,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["952"],"URL":"https:\/\/doi.org\/10.1007\/s12035-018-0952-9","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,7]]},"assertion":[{"value":"10 August 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Institutional Review Board of the Third Military Medical University. Written consent forms were obtained from each individual patient or their legal guardians.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}